For the second time this year there had been financial cuts announced for treatment for NET patients in England. Firstly Everolimus, now PRRT. You can read more on the net patient foundation site at
http://www.netpatientfoundation.org/2015/09/prrt-withdrawn-from-the-cancer-drugs-fund/


